311. Deputy Colm Burke asked the Minister for Health if he will correspond with the National Centre for Pharmacoeconomics to reconsider its decision regarding the reimbursement of the cost of the gene therapy treatment Luxturna in that early administration of this medicine can lead to greater, life-enhancing benefits for those suffering with degenerative retinal disease; and if he will make a statement on the matter. [2985/21]

Summary

311. Deputy Colm Burke asked the Minister for Health if he will correspond with the National Centre for Pharmacoeconomics to reconsider its decision regarding the reimbursement of the cost of the gene therapy treatment Luxturna in that early administration of this medicine can lead to greater, life-enhancing benefits for those suffering with degenerative retinal disease; and if he will make a statement on the matter. [2985/21]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 21 January 2021

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.